文献速递心境障碍

重度抑郁症患者血浆外泌体miR-151a-3p改变及相关多模态神经影像模式

Alterations in miR-151a-3p of plasma-derived exosomes and associated multimodal neuroimaging patterns in major depressive disorder.
PubMed 文献 · Mol Psychiatry · 2025-07-09

该研究在70例重度抑郁症(MDD)患者和71例健康对照的训练集中,识别血浆外泌体miR-151a-3p与多模态MRI特征的共变模式;在45例MDD和43例健康对照的测试集中,基于miR-151a-3p相关多模态MRI特征的SVM模型分类准确率达92.05%,高于仅用组间差异多模态MRI特征的70.45%;28例MDD患者治疗6个月后10例有效者miR-151a-3p显著上调且fMRI指标变化;动物实验初步探索相关信号通路。

要点

  • MDD患者血浆外泌体miR-151a-3p水平显著低于健康对照,并与前扣带回、视觉皮层及默认网络等fMRI指标异常相关。
  • 基于miR-151a-3p相关多模态MRI特征的SVM模型区分MDD与健康对照的准确率为92.05%,优于仅用组间差异多模态MRI特征的70.45%。
  • 28例MDD患者抗抑郁治疗6个月后10例达到临床显著应答(HAMD评分减分率超过50%),其miR-151a-3p显著上调且fMRI指标变化。

核心结论

  • 联合血浆外泌体miR-151a-3p表达与其相关多模态MRI模式可构建MDD诊断模型,可能作为新型诊断工具。

研究设计与样本

  • 训练集为70例MDD患者和71例健康对照,测试集为45例MDD患者和43例健康对照,采用多模态MRI融合算法识别miR-151a-3p相关影像共变模式。
  • 纵向验证纳入28例接受抗抑郁治疗6个月的MDD患者,并在抑郁样小鼠中初步探索相关信号通路。

主要发现

  • MDD患者血浆外泌体miR-151a-3p水平显著低于健康对照,并与前扣带回、视觉皮层及默认网络等fMRI指标异常变化相关。
  • 基于miR-151a-3p相关多模态MRI特征的SVM模型分类准确率为92.05%,高于仅用组间差异多模态MRI特征的70.45%。
  • 28例MDD患者中10例治疗6个月后达到临床显著应答(HAMD评分减分率超过50%),这10例患者血浆外泌体miR-151a-3p显著上调且fMRI指标变化。
  • 动物实验显示,降低前扣带回miR-151-3p表达诱导小鼠抑郁样行为,而提高前扣带回hsa-miR-151a-3p表达可缓解慢性不可预见性温和应激暴露小鼠的抑郁样行为。

关键数值与推荐

  • SVM模型基于miR-151a-3p相关多模态MRI特征区分MDD与健康对照的准确率为92.05%。
  • 仅使用组间差异多模态MRI特征时诊断准确率为70.45%。
  • 临床显著应答定义为HAMD评分减分率超过50%,28例MDD患者中10例达到该标准。

临床怎么用

  • 提示血浆外泌体miR-151a-3p联合多模态MRI特征可能辅助MDD诊断,但尚未进入临床常规应用。
  • miR-151a-3p水平及fMRI指标变化可能作为抗抑郁治疗应答的潜在监测指标,需进一步验证。

局限性

  • 研究样本量有限,训练集和测试集规模较小,结论需更大样本验证。
  • 动物实验仅初步探索相关信号通路,机制尚未完全阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Magnetic resonance imaging (MRI) has been recognized as a valuable tool for achieving 'reification of clinical diagnosis' of major depressive disorder (MDD). However, the reliability and validity of MRI results are often compromised by genetic, environmental, and clinical heterogeneity within test samples. Here, we combined MRI with other clinical findings using multimodal MRI fusion algorithm to construct a data-driven, bottom-up diagnostic approach. The covariation patterns between the multimodal MRI features and differential expression of exosomal microRNA (miRNA) were identified on a subset of 70 MDD patients and 71 healthy controls (HCs) (served as a training set) as classification features, whereas data from the other 45 MDD patients and 43 HCs served as a test set. Furthermore, longitudinal data from 28 MDD patients undergoing antidepressant treatment for six months were utilized to validate the identified biomarkers, and related signaling pathways were initially explored in depression-like mice. Plasma exosome-derived miR-151a-3p levels were found to be significantly lower in MDD patients compared to HCs and correlated with abnormal changes in functional MRI (fMRI) metrics in the anterior cingulate cortex (ACC), visual cortex, and default mode network, etc. Then, these multimodal MRI features associated with miR-151a-3p expression distinguished MDD patients from HCs with high classification accuracy of 92.05% in support vector machine (SVM) model, outperforming the diagnostic rate when only multimodal MRI features with intergroup differences were entered (70.45%). Furthermore, 10 out of 28 MDD patients exhibited a clinically significant response to the treatment (a reduction of over 50% in Hamilton Rating Scale for Depression (HAMD) score). The significant upregulation of plasma exosomal miR-151a-3p levels and changes of fMRI indicators were also observed in these 10 patients after treatment of six months. Animal experiments have shown that reducing the expression of miR-151-3p in ACC induces depression-like behaviors in mice, while elevating hsa-miR-151a-3p expression in ACC alleviates the depression-like behaviors of mice exposed to chronic unpredictable mild stress. Our study proposed an innovative diagnostic model of MDD by combining the plasma exosome-derived miR-151a-3p expression with its associated multimodal MRI patterns, potentially serving as a novel diagnostic tool.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Liang W, Hou L, Wang W, et al. Alterations in miR-151a-3p of plasma-derived exosomes and associated multimodal neuroimaging patterns in major depressive disorder. Mol Psychiatry. 2025. PMID: 40634531. doi:10.1038/s41380-025-03102-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。